scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1113293242 |
P356 | DOI | 10.1186/S40169-019-0228-7 |
P932 | PMC publication ID | 6451934 |
P698 | PubMed publication ID | 30957197 |
P50 | author | Soudeh Ghafouri-Fard | Q38548826 |
Mohammad Taheri | Q56246002 | ||
P2093 | author name string | Mehrdokht Mazdeh | |
Shahriar Kargar Monhaser | |||
P2860 | cites work | Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis | Q35116652 |
New management algorithms in multiple sclerosis | Q38206631 | ||
Determination of cytokine levels in multiple sclerosis patients and their relevance with patients' response to Cinnovex. | Q38731809 | ||
Heterogeneity in multiple sclerosis: scratching the surface of a complex disease. | Q41295973 | ||
Meta-analysis of the Age-Dependent Efficacy of Multiple Sclerosis Treatments | Q47200732 | ||
The multiple sclerosis severity score (MSSS) predicts disease severity over time | Q83177562 | ||
The effectiveness of fingolimod in a Portuguese real-world population | Q89156361 | ||
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” | Q22252938 | ||
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis | Q26771635 | ||
A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis | Q28270998 | ||
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis | Q28271008 | ||
Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial | Q30789784 | ||
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis | Q34624835 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | fingolimod | Q425137 |
relapsing-remitting multiple sclerosis | Q18555066 | ||
P304 | page(s) | 11 | |
P577 | publication date | 2019-04-08 | |
P1433 | published in | Clinical and translational medicine | Q27724586 |
P1476 | title | A non-randomized clinical trial to evaluate the effect of fingolimod on expanded disability status scale score and number of relapses in relapsing-remitting multiple sclerosis patients | |
P478 | volume | 8 |
Search more.